{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/0955-2900#drug","name":"Insulin glargine U-300 Max","alternateName":"insulin glargine","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"0955-2900"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"BLA206538"},{"@type":"PropertyValue","propertyID":"UNII","value":"2ZM8CX04RZ"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"99ea856d-9562-443a-9422-1006a3cff2f4"}],"activeIngredient":"INSULIN GLARGINE","administrationRoute":["SUBCUTANEOUS"],"dosageForm":"INJECTION, SOLUTION","manufacturer":{"@type":"Organization","name":"Sanofi-Aventis U.S. LLC"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/BLA206538","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=99ea856d-9562-443a-9422-1006a3cff2f4","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0955-2900"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-02T10:06:46.578Z"}}